propranolol has been researched along with Lipid Metabolism, Inborn Error in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lipid storage myopathies are a rare but serious cause of muscle weakness characterised by the accumulation of abnormal amounts of neutral fat in type 1 fibres." | 1.26 | Lipid storage myopathy: successful treatment with propranolol. ( Jellinek, EH; Martyn, C; Webb, JN, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martyn, C | 1 |
| Jellinek, EH | 1 |
| Webb, JN | 1 |
1 other study available for propranolol and Lipid Metabolism, Inborn Error
| Article | Year |
|---|---|
Lipid storage myopathy: successful treatment with propranolol.
Topics: Adult; Creatine Kinase; Humans; L-Lactate Dehydrogenase; Lipid Metabolism, Inborn Errors; Male; Micr | 1981 |